IPO and initial portfolio
Listing funded the initial exploration programme. Garden Gully was sold for a mixture of cash and Sipa shares, not recurring operating revenue.
Miramar’s five-year financial story is an exploration-funding cycle: a growing portfolio carrying value, recurring losses, and repeated equity issues to finance work. FY2025 rebuilt cash, but capitalised exploration dominated the balance sheet and the auditor still highlighted material going-concern uncertainty.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Balance at 30 June, before later funding.
Carrying amount, not a mineral valuation.
Before issue costs and lease payments.
Continued funding remains important.
The October 2020 IPO funded work at Gidji and Glandore. Focus later shifted towards Gascoyne and Capricorn Orogen projects. These are exploration activities, not a history of operating-mine sales.
The distinction that matters is between money spent, amounts expensed and costs retained as exploration assets. Grants and tenement relinquishments change that carrying value, while new shares finance the cash requirement.
Listing funded the initial exploration programme. Garden Gully was sold for a mixture of cash and Sipa shares, not recurring operating revenue.
A placement raised A$2.4m before costs; exploration additions and investing cash use remained material.
Management shifted its focus to earlier-stage Gascoyne projects. EIS support was secured for Whaleshark drilling; the asset movement also includes an R&D offset.
Work focused on the Capricorn Orogen and Chain Pool was added. Lakeside and Langwell were relinquished, leading to exploration impairments.
Rights and placement issues supported cash. A non-binding Bangemall JV term sheet outlined potential staged funding, while the accounts retained going-concern uncertainty.
Employee, consultant and marketing expenses eased after their earlier peaks, but impairment kept the FY2024–FY2025 losses elevated. An abandoned tenement can produce an accounting charge even when the original exploration cash was spent in an earlier period.
The FY2021 Garden Gully consideration included shares as well as cash. It should not be read as mine turnover. Nor are unrecognised tax losses a source of available funding: the FY2025 notes do not recognise the related deferred-tax benefits because future taxable profit was not considered probable.
A$ million
AI-generated presentation · values from What drove the annual loss; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Loss after income tax | (1.020) | (1.375) | (1.390) | (1.906) | (1.635) |
| Employee benefits expense | (0.140) | (0.496) | (0.486) | (0.374) | (0.310) |
| Consultants expense | (0.331) | (0.217) | (0.252) | (0.295) | (0.275) |
| Marketing and public relations | (0.083) | (0.176) | (0.142) | (0.161) | (0.088) |
| Occupancy expense | (0.027) | (0.081) | (0.093) | (0.035) | (0.035) |
| Exploration and evaluation expense | (0.114) | (0.134) | (0.179) | (0.135) | (0.139) |
| Exploration write-off / impairment | (0.220) | 0.000 | 0.000 | (0.649) | (0.566) |
| Other expenses | (0.212) | (0.200) | (0.184) | (0.224) | (0.171) |
| Depreciation of non-current assets — separate P&L line | (0.031) | (0.058) | (0.044) | (0.028) | (0.056) |
| Other / interest income | 0.002 | 0.010 | 0.011 | 0.009 | 0.008 |
A$ million; expenses and losses are negative. Selected material components, not a full summation of profit. Occupancy already includes right-of-use depreciation; do not add it again to the separate depreciation line.
FY2021 also reported A$0.150m income from the Garden Gully disposal, and FY2022 A$0.008m other ordinary income. These are not mine sales. Income tax was nil in the statutory statements.
FY2022 write-offs are nil in the full income statement; FY2023 no impairment is explicitly confirmed in the annual narrative and FY2024 comparative. FY2025 P&L impairment differs by A$1 from the exploration roll-forward; each reported basis is preserved.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FY2025 financing more than covered the combined operating and investing cash outflows, lifting closing cash. However, operating outflow benefited from the positive net exploration/GST line and working-capital movements; gross supplier payments did not fall in parallel.
The grant classification differs between years, and the capitalised asset note records a broader grant offset than the FY2025 investing receipt. Keep net operating cash, gross investing exploration payments and accounting additions separate.
A$ million
AI-generated presentation · values from Exploration was funded by capital, not operating income; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Exploration was funded by capital, not operating income; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net operating cash flow | (0.658) | (1.046) | (1.260) | (0.797) | (0.597) |
| Net investing cash flow | (1.952) | (2.781) | (2.676) | (1.088) | (1.715) |
| Net financing cash flow | 7.337 | 2.108 | 1.002 | 1.876 | 3.024 |
| Exploration and evaluation payments — investing | (1.530) | (2.705) | (2.667) | (1.061) | (1.995) |
| Gross cash proceeds from equity issues | 8.010 | 2.443 | 1.200 | 2.162 | 3.379 |
| Cash equity-issue costs | (0.650) | (0.255) | (0.113) | (0.262) | (0.321) |
| Lease liability repayments | (0.023) | (0.080) | (0.085) | (0.024) | (0.034) |
A$ million; cash flow, not expense or equity accounting. Investing also contains tenement acquisitions, plant payments and selected disposal/grant receipts.
Grant cash is not classified uniformly: FY2024 A$0.199m appears in operating activities; FY2025 A$0.291m appears in investing. This is one reason operating cash flow alone does not measure annual exploration intensity.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Payments to suppliers and employees | (0.681) | (0.895) | (1.050) | (0.878) | (1.002) |
| Net exploration line — operating, inclusive of GST | 0.022 | (0.161) | (0.221) | (0.126) | 0.397 |
| Interest received | 0.001 | 0.010 | 0.011 | 0.008 | 0.008 |
The operating exploration line is positive in FY2021 and FY2025 as reported. It is not recast as a negative gross drilling payment. The accounting policy classifies recoverable investing/financing GST components in operating cash flow.
The separate FY2024 operating grant receipt completes that year’s subtotal. FY2025 supplier/employee payments remained about A$1m despite a lower net operating outflow.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2025 |
|---|---|
| Statutory loss | (1.635) |
| Add back exploration write-off | 0.566 |
| Non-current asset depreciation | 0.056 |
| Right-of-use depreciation | 0.032 |
| Government grant adjustment | (0.291) |
| Receivables movement | 0.233 |
| Payables and provisions movement | 0.429 |
| Net operating cash flow | (0.597) |
Selected material reconciling items; the issuer also includes share payments, fair-value movements, acquisition payment, interest and fixed-asset disposal adjustments. The table is not presented as an exhaustive sum.
Positive working-capital movements supported cash relative to the loss. They are not revenue growth, and the noncash exploration write-off did not itself require a new cash payment.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Exploration carrying value grew while cash was drawn down and replenished. Early acquisitions established the portfolio; later additions were partly offset by grants and relinquishments. The FY2023 gross-versus-net difference is fully explained by the R&D offset, not a missing year of data.
Recoverability remains conditional on tenure, future exploration and development or sale. The potential EIS support for work after June 2025 was not booked as an asset because of timing uncertainty. A proposed JV earn-in is likewise not current cash or a completed disposal.
A$ million
AI-generated presentation · values from Consolidated balance sheet: exploration assets versus liquid funds; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 5.055 | 3.336 | 0.402 | 0.392 | 1.104 |
| Capitalised exploration and evaluation | 3.039 | 5.771 | 8.167 | 8.745 | 9.905 |
| Total assets — FY2025 calculated | 8.519 | 9.511 | 9.098 | 9.360 | 11.246 |
| Total liabilities | 0.707 | 0.542 | 0.308 | 0.395 | 0.836 |
| Net assets / total equity | 7.812 | 8.969 | 8.790 | 8.965 | 10.410 |
| Trade and other payables | 0.377 | 0.410 | 0.223 | 0.332 | 0.755 |
| Current provisions | 0.267 | 0.050 | 0.052 | 0.041 | 0.047 |
A$ million at 30 June; Group, not parent-only. FY2025 total assets are calculated: reported equity A$10.409887m + liabilities A$0.835666m = A$11.245553m. Other years use reported asset totals.
Capitalised exploration is part of total assets, not additional to it. Its recovery depends on tenure, exploration success and development or sale; it is neither available cash nor an estimate of ore value.
FY2025 liabilities include A$0.033135m lease liability. A separate borrowing line is not supplied; that is not converted into a claim of zero debt.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Opening carrying amount | 5.771 | 8.167 | 8.745 |
| Gross exploration additions | 2.667 | 1.426 | 2.157 |
| R&D / government grant offsets | (0.271) | (0.199) | (0.432) |
| Impairment of relinquished tenements | 0.000 | (0.649) | (0.566) |
| Closing carrying amount | 8.167 | 8.745 | 9.905 |
FY2023 gross additions of A$2.667257m less the A$0.271382m R&D offset produce the A$2.395875m net capitalised increase described in the directors’ review. These are different bases, not two rival estimates of spending.
FY2024 impairment relates to ceased/relinquished Lakeside and Langwell interests. FY2025 grants comprise R&D A$0.291413m and EIS co-funding A$0.140110m. Grant asset offsets and the cash-flow receipt line are not identical totals.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FY2025’s rights issue and two placements rebuilt liquidity while substantially increasing the share base. Shares used to pay drilling invoices reduce the immediate cash requirement but remain a noncash equity transaction, not customer receipts.
The auditor highlighted material uncertainty related to going concern. Directors cited subsequent funding, staged exploration spending and future equity or JV options; these plans do not remove the financing dependency or turn the exploration asset into cash.
The July 2025 SPP and first August 2025 settlement under the Topdrill agreement fall after the June balance date. The Debnal option also remained unexercised at year-end, so its possible exercise consideration is not treated as a completed acquisition.
A$ million
AI-generated presentation · values from Equity accumulated while losses continued; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Issued share capital — cumulative balance | 8.269 | 10.701 | 11.291 | 13.212 | 16.093 |
| Reserves | 0.753 | 0.853 | 1.465 | 0.944 | 0.425 |
| Accumulated losses | (1.209) | (2.585) | (3.966) | (5.192) | (6.108) |
A$ million. Issued capital is not the same as gross cash received: noncash issues, issue costs and reserve movements affect equity. Accumulated losses can also change through transfers within equity, not only the current-year P&L.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2025 |
|---|---|
| Rights issue — gross cash proceeds | 1.579 |
| January–March placement — gross cash proceeds | 0.179 |
| April–June placement — gross cash proceeds | 1.621 |
| Drilling services settled in shares — noncash | 0.022 |
The three cash issues reconcile to A$3.379119m gross equity cash inflow. The rights issue issued 197.390m shares at A$0.008; the two placements together issued 600m shares at A$0.003.
The service settlement issued a further 2.044m shares and is not added to cash receipts. The July 2025 SPP and August Topdrill settlement are after the balance date, not FY2025 financing cash.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.